Gilder Gagnon Howe & Co. LLC Trims Position in Option Care Health, Inc. $OPCH

Gilder Gagnon Howe & Co. LLC trimmed its position in Option Care Health, Inc. (NASDAQ:OPCH) by 5.8% during the 2nd quarter, HoldingsChannel reports. The firm owned 828,583 shares of the company’s stock after selling 51,243 shares during the period. Gilder Gagnon Howe & Co. LLC’s holdings in Option Care Health were worth $26,912,000 as of its most recent filing with the SEC.

A number of other large investors have also made changes to their positions in the company. Durable Capital Partners LP lifted its stake in shares of Option Care Health by 134.2% in the 2nd quarter. Durable Capital Partners LP now owns 8,237,577 shares of the company’s stock worth $267,557,000 after purchasing an additional 4,720,988 shares during the period. Norges Bank purchased a new stake in Option Care Health during the second quarter valued at approximately $69,932,000. Arrowstreet Capital Limited Partnership raised its position in Option Care Health by 109.0% in the second quarter. Arrowstreet Capital Limited Partnership now owns 3,410,394 shares of the company’s stock worth $110,770,000 after acquiring an additional 1,778,279 shares during the period. Jennison Associates LLC boosted its stake in shares of Option Care Health by 145.6% during the 2nd quarter. Jennison Associates LLC now owns 2,138,248 shares of the company’s stock worth $69,450,000 after acquiring an additional 1,267,660 shares during the last quarter. Finally, Fuller & Thaler Asset Management Inc. boosted its stake in shares of Option Care Health by 30.8% during the 1st quarter. Fuller & Thaler Asset Management Inc. now owns 4,204,481 shares of the company’s stock worth $146,947,000 after acquiring an additional 989,048 shares during the last quarter. 98.05% of the stock is currently owned by institutional investors.

Insider Buying and Selling

In other Option Care Health news, Director Harry M. Jansen Kraemer, Jr. purchased 38,000 shares of the company’s stock in a transaction on Monday, November 3rd. The stock was acquired at an average cost of $25.98 per share, for a total transaction of $987,240.00. Following the purchase, the director directly owned 413,390 shares of the company’s stock, valued at $10,739,872.20. This trade represents a 10.12% increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Corporate insiders own 0.64% of the company’s stock.

Option Care Health Price Performance

Shares of Option Care Health stock opened at $33.24 on Friday. The company has a market capitalization of $5.28 billion, a price-to-earnings ratio of 26.38, a PEG ratio of 2.22 and a beta of 0.80. The company has a quick ratio of 1.05, a current ratio of 1.56 and a debt-to-equity ratio of 0.85. The stock’s 50-day simple moving average is $28.74 and its 200-day simple moving average is $29.36. Option Care Health, Inc. has a 52 week low of $22.29 and a 52 week high of $35.53.

Analyst Upgrades and Downgrades

Several research firms have recently commented on OPCH. TD Cowen reduced their price objective on Option Care Health from $30.00 to $27.00 and set a “hold” rating for the company in a research note on Monday, November 3rd. Citizens Jmp reduced their price target on Option Care Health from $38.00 to $36.00 and set a “market outperform” rating for the company in a research report on Friday, October 31st. Barrington Research reaffirmed an “outperform” rating and issued a $38.00 price objective on shares of Option Care Health in a research note on Friday, October 31st. Cowen began coverage on Option Care Health in a research note on Thursday, October 2nd. They set a “hold” rating for the company. Finally, Citigroup reissued an “outperform” rating on shares of Option Care Health in a report on Friday, October 31st. Eleven analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $36.27.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.